TITLE

Independent predictors of cirrhosis in hispanic patients with non alcoholic steatohepatitis (NASH)

AUTHOR(S)
Alazmi, Waleed; O'Loughlin, Colm J; Molina, Enrique
PUB. DATE
September 2003
SOURCE
American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS95
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article "Independent Predictors of Cirrhosis in Hispanic Patients With Non Alcoholic Steatohepatitis (NASH)," by Waleed Alazmi, Colm J. O'Loughlin, and Enrique Molina is presented.
ACCESSION #
66954302

 

Related Articles

  • The Hepatitis C Patient: Functional Assessment and Effective Botanical Remedies. Calvino, Nicholas // Townsend Letter for Doctors & Patients;Dec2002, Issue 233, p74 

    Focuses on the functional assessment and botanical remedies of patient with hepatitis C. Symptoms of the disease; Causes of chronic liver disease; Percentage of hepatitis C patients with cirrhosis.

  • De novo acute infection and reactivation of hepatitis B virus in established cirrhosis. Theodossi, A.; Wilkinson, S.P.W.; Portmann, B.; White, Y.; Eddleston, A.L.W.F.; Williams, Roger; Zuckerman, A.J. // British Medical Journal;10/13/1979, Vol. 2 Issue 6195, p893 

    Examines the evidence of acute hepatitis B infection in patients with cirrhosis in Great Britain. Acquisition of the infection from blood transfusion; Relation of hepatitis B virus to immunosuppressive drug treatment; Effects on the reactivation of dormant virus infection.

  • A giant spider nevus in a patient of hepatitis C-related liver cirrhosis: A rare presentation. Sood, Ajit; Gupta, Rahul; Midha, Vandana // International Journal of Applied & Basic Medical Research;Sep-Dec2015, Vol. 5 Issue 3, p206 

    Spider nevi are benign vascular lesions mostly seen in patients with decompensated liver cirrhosis. Mostly, these are seen in the superior vena cava distribution and are small with pinhead size central vessel. Giant spider nevus is rarely seen and hence this report.

  • INVESTIGATION OF HEPATIC BLOOD FLOW USING MICROBUBBLE ENHANCED ULTRASOUND IN THE DIAGNOSIS OF CIRRHOSIS. Anderloni, A.; MacQuarrie, J.; Leen, E.; Oein, K.; Angerson, W.J.; Morris, A.J. // Gut;Apr2003 Supplement 1, Vol. 52, pA3 

    Background: It has been previously shown that alterations in hepatic haemodynamics can be assessed in cirrhotic patients by measuring the hepatic vein transit time of an ultrasound contrast agent. Aim: To evaluate the clinical usefulness of a new contrast agent SonoVue, in differentiating...

  • Hepatitis B and adefovir depivoxil.  // AIDS Patient Care & STDs;Apr97, Vol. 11 Issue 2, p103 

    Reports that HIV-infected persons infected with hepatitis B (HBV) are at risk for developing liver cirrhosis. Effectiveness and safety of adefovir depivoxil to treat HBV.

  • Hepatic Encephalopathy in Liver Cirrhosis: Pathogenesis, Diagnosis and Management. Gerber, T.; Schomerus, H. // Drugs;Dec2000, Vol. 60 Issue 6, p1353 

    The pathogenesis of hepatic encephalopathy (HE) is unknown. Many theories have been proposed. Most established therapies are based on such theories but since no theory has have ever been proved, therapies have to be considered empiric. The spectrum of HE ranges from minimal cerebral functional...

  • Recombinant Hepatitis B Vaccination in Renal Failure Patients. D. Vlassopoulos // Current Pharmaceutical Biotechnology;Apr2003, Vol. 4 Issue 2, p141 

    Hepatitis B (HB) in haemodialysis patients results in morbidity and mortality, through chronicity, which leads to cirrhosis and liver carcinoma, even after renal transplantation. Hepatitis B vaccination is protective against HB virus infection. Suppressed immunity in renal failure leads to low...

  • Review: Flumazenil leads to clinical and electroencephalographic improvement in hepatic encephalopathy in patients with cirrhosis. Reichen, Jurg // ACP Journal Club;Jan/Feb2003, Vol. 138 Issue 1, p15 

    Presents a study that investigated the effectiveness of flumazenil in treating hepatic encephalopathy in patients with cirrhosis. Data sources; Selection of studies used; Results and findings.

  • Hepatitis prevention in children begins with immunization. Zacharyczuk, Colleen // Infectious Diseases in Children;Aug2012, Vol. 25 Issue 8, p1 

    The article reports on the importance of immunization in preventing hepatitis from progressing to chronic liver disease over decades, leading to cirrhosis and high rates of hepatocellular carcinoma.

  • Obese children with steatohepatitis can develop cirrhosis in childhood. P. Molleston, Jean; White, Frances; Teckman, Jeffrey; Fitzgerald, Joseph F. // American Journal of Gastroenterology;Sep2002, Vol. 97 Issue 9, p2460 

    Nonalcoholic steatohepatitis, in which fatty change and inflammation of the liver occur in the absence of excess alcohol intake, is increasingly recognized in obese children. Although fibrosis is common in pediatric nonalcoholic steatohepatitis, cirrhosis has been reported rarely. The two boys...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics